Literature DB >> 10704523

Protein structure controls the processing of the N-linked oligosaccharides and glycosylphosphatidylinositol glycans of variant surface glycoproteins expressed in bloodstream form Trypanosoma brucei.

N Zitzmann1, A Mehlert, S Carrouée, P M Rudd, M A Ferguson, S Carroué.   

Abstract

The variant surface glycoproteins (VSGs) of Trypanosoma brucei are a family of homodimeric glycoproteins that adopt similar shapes. An individual trypanosome expresses one VSG at a time in the form of a dense protective mono-layer on the plasma membrane. VSG genes are expressed from one of several polycistronic transcription units (expression sites) that contain several expression site associated genes. We used a transformed trypanosome clone expressing two different VSGs (VSG121 and VSG221) from the same expression site (that of VSG221) to establish whether the genotype of the trypanosome clone or the VSG structure itself controls VSG N-linked oligosaccharide and GPI anchor glycan processing. In-gel release and fluorescent labeling of N-linked oligosaccharides and on-blot fluorescent labeling and release of GPI anchor glycans were employed to compare the carbohydrate structures of VSG121 and VSG221 when expressed individually in wild-type trypanosome clones and when expressed together in the transformed trypanosome clone. The data indicate that the genotype of the trypanosome clone has no effect on the N-linked oligosaccharide structures present on a given VSG variant and only a minor effect on the GPI anchor glycans. The latter is most likely an effect of changes in inter-VSG packing when two VGSs are expressed simultaneously. Thus, N-linked oligosaccharide and GPI anchor processing enzymes appear to be constitutively expressed in bloodstream form African trypanosomes and the tertiary and quaternary structures of the VSG homodimers appear to dictate the processing and glycoform microheterogeneity of surface-expressed VSGs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704523     DOI: 10.1093/glycob/10.3.243

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  Ubiquitylation and developmental regulation of invariant surface protein expression in trypanosomes.

Authors:  Ka Fai Leung; Fay S Riley; Mark Carrington; Mark C Field
Journal:  Eukaryot Cell       Date:  2011-05-13

2.  Steric constraints control processing of glycosylphosphatidylinositol anchors in Trypanosoma brucei.

Authors:  Carolina M Koeller; Calvin Tiengwe; Kevin J Schwartz; James D Bangs
Journal:  J Biol Chem       Date:  2020-01-13       Impact factor: 5.157

Review 3.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

4.  Exposure of Trypanosoma brucei to an N-acetylglucosamine-binding lectin induces VSG switching and glycosylation defects resulting in reduced infectivity.

Authors:  Víctor M Castillo-Acosta; Luis M Ruiz-Pérez; Els J M Van Damme; Jan Balzarini; Dolores González-Pacanowska
Journal:  PLoS Negl Trop Dis       Date:  2015-03-06

5.  Application of electrospray mass spectrometry to the structural determination of glycosylphosphatidylinositol membrane anchors.

Authors:  Isabelle R E Nett; Angela Mehlert; Douglas Lamont; Michael A J Ferguson
Journal:  Glycobiology       Date:  2010-01-24       Impact factor: 4.313

6.  A function for a specific zinc metalloprotease of African trypanosomes.

Authors:  Paul M Grandgenett; Keiko Otsu; Helen R Wilson; Mary E Wilson; John E Donelson
Journal:  PLoS Pathog       Date:  2007-10-19       Impact factor: 6.823

7.  Carbohydrate-Binding Non-Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine Models.

Authors:  Víctor M Castillo-Acosta; Luis M Ruiz-Pérez; Juan Etxebarria; Niels C Reichardt; Miguel Navarro; Yasuhiro Igarashi; Sandra Liekens; Jan Balzarini; Dolores González-Pacanowska
Journal:  PLoS Pathog       Date:  2016-09-23       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.